Navigation Links
PDI Reports 2011 Fourth Quarter and Year End Financial Results
Date:3/7/2012

PARSIPPANY, N.J., March 7, 2012 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the fourth quarter and year ended December 31, 2011. Summary financial and operating highlights include:

  • Full year 2011 revenue of $157.3 million increased 17% compared to 2010. 2011 and 2010 revenue excludes the company's Pharmakon business unit, which was sold in the fourth quarter and is shown in discontinued operations. Full year 2011 operating loss of $4.7 million decreased by 32% compared to 2010; fourth quarter 2011 operating loss of $2.4 million decreased by 27% compared to 2010.
  • Excluding Group DCA operations and a $2.9 million one-time charge for the buy-out of certain potential earn-out obligations, the company achieved 2011 full year operating profit of $3.4 million and 2011 fourth quarter operating profit of $1.8 million.
  • Cash flow from operations was $2.0 million for the full year of 2011.
  • Recently signed renewal agreements with a top 5 global pharmaceutical client and a specialty pharmaceutical client, which, together, are expected to generate approximately $48 million of revenue in 2012.

  • Condensed Summary Statement of Continuing Operations($ in millions, except per share data)4th Quarter EndedYear EndedDecember 31,*December 31,*2011201020112010Revenue, net$
    38.3$
    42.3$
    57.3$
    34.6Gross profit8.78.132.526.6Operating expenses:   Compensation expense4.54.719.716.3   Other SG&A3.75.314.615.2DCA buyout and related costs2.9-2.9-Facilities realignment-1.4-2.0Total operating expenses11.111.437.233.5Operating loss$
    (2.4)$
    (3.3)$
    (4.7)$
    (6.9)Other income (expense), net0.1--0.1(Benefit) provision for income tax(0.4)0.2(0.9)0.4Loss from continuing operations$
    (1.9)$
    (3.5)$
    (3.8)$
    (7.2)Diluted loss per share from continuingoperations$
    (0.13)$
    (0.25)$
    (
    '/>"/>

    SOURCE PDI, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results
    2. Cell Therapeutics, Inc. (CTI) Reports Fourth Quarter and Year-End Financial Results and Milestones
    3. Stereotaxis Reports 2011 Financial Results; Provides 2012 Milestones
    4. ZONARE Reports Fourth Quarter and 2011 Results
    5. IRIDEX Reports 2011 Fourth Quarter and Year-End Results
    6. Cumberland Pharmaceuticals Reports 2011 Annual Financial Results
    7. Nektar Therapeutics Reports Fourth Quarter and Year-End 2011 Financial Results
    8. Angeion Corporation Reports First Quarter Fiscal Year 2012 Operating Results
    9. ERT Reports Fourth Quarter and Full Year 2011 Operating Results
    10. Valeant Pharmaceuticals Reports 2011 Fourth Quarter Financial Results
    11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... Rose, baseball,s all-time hits leader, is the new spokesperson for ... Pharma has announced. "Pete,s a Hall of Famer ... on board with Myoflex," said Ducere Pharma Chief Executive Officer ... is known across all generations. The passion and intensity that ...
    (Date:1/23/2015)... 2015  Now available for sale, The Armor1 Ankle Roll ... ankle sprains by cushioning the ankle from an inversion ... the outside of any shoe type and allows the ... offering protection against sprains. With customers in physical therapy, ...
    (Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
    Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
    ... WALTHAM, Mass. , March 22 Interleukin Genetics, Inc. (NYSE ... the NYSE Amex LLC (the "Exchange") has granted the Company an extension ... will remain listed up to June 23, 2010 , subject to ... towards the Company,s plan to regain compliance. , ...
    ... and Manufacturers of America (PhRMA) issued the following statement today on passage of comprehensive health care reform and accompanying reconciliation legislation in the U.S. House of Representatives: , ... , ... ... ...
    Cached Medicine Technology:NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 2NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 3PhRMA Statement on Health Care Reform 2PhRMA Statement on Health Care Reform 3PhRMA Statement on Health Care Reform 4PhRMA Statement on Health Care Reform 5
    (Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
    (Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
    (Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
    (Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Lower-Auto-Insurance.com has released a ... kit in a car for reducing the costs of an ... will also be able to get lower prices for their vehicle ... an important role in determining policy costs. Because of this, ...
    Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
    ... MEDmarketplace.com announced today that it has been awarded a ... contracting entity for the Sisters of Mercy Hospital System ... marketplace for selling surplus medical equipment and supplies. ... the agreement, Mercy,s 18 acute care hospitals, two heart ...
    ... CHICAGO, Dec. 4 The Neurologic & Orthopedic Hospital of,Chicago ... Chicago,Red Stars, a charter member of Women,s Professional Soccer, a ... world. The NOHC will,also be an official partner of ... , Heading the medical ...
    ... format for its “OneMedForum 2009” finance conference, ... San Francisco at the Sir Francis Drake ... disrupters” affecting each of the following medtech ... and Neurostimulation; Cardiology; Urology and Sexual Health; ...
    ... Kenneth K. Westbrook, a leading executive in Southern ... Chief Executive Officer of Integrated Healthcare Holdings, Inc., effective ... hospitals in Orange County, California: Western Medical Center -- ... Center and Coastal Communities Hospital. , ...
    ... blood pressure does not improve a common form of ... international study. , The study, which included researchers ... leadership positions, appears in this week,s issue of the ... , The findings are disappointing to researchers, who continue ...
    ... programs to help consumers make informed health care decisions , ... While data indicates that area doctors are doing a ... health of their employees, none of this matters if consumers ... to research released today by the Dallas-Fort Worth Business Group ...
    Cached Medicine News:Health News:MEDmarketplace.com Signs Contract with Resource Optimization & Innovation (ROi) to Sell Surplus Hospital Equipment 2Health News:MEDmarketplace.com Signs Contract with Resource Optimization & Innovation (ROi) to Sell Surplus Hospital Equipment 3Health News:Neurological & Orthopedic Named Official Hospital of Chicago Red Stars Women's Pro Soccer Team 2Health News: OneMedPlace announces panels for "OneMedForum 2009: Disrupters and Drivers in Eight Areas of Medical Technology" -- CEOs and investors to meet in unique format of focused sessions 2Health News:Integrated Healthcare Holdings, Inc. Announces New Chief Executive Officer 2Health News:Study finds treatment fails to improve common form of heart failure 2Health News:Study finds treatment fails to improve common form of heart failure 3Health News:Partnership for Peak Healthcare Performance Research Shows Consumers' Lack Involvement in Managing Their Health 2Health News:Partnership for Peak Healthcare Performance Research Shows Consumers' Lack Involvement in Managing Their Health 3Health News:Partnership for Peak Healthcare Performance Research Shows Consumers' Lack Involvement in Managing Their Health 4
    The Freedom Clear catheter is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath for every day wear....
    ... Natural® all-silicone non-adhesive male external catheter ... of latex-related allergic reactions. It is ... to change external catheters several times ... Natural catheter comes with an adjustable ...
    Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use....
    ... Used for stone manipulation ... urinary tract. Enhanced wire ... dilation in the ureter. ... easy, ergonomic one-handed operation. ...
    Medicine Products: